Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Zhu, HD; Li, HL; Huang, MS; Yang, WZ; Yin, GW; Zhong, BY; Sun, JH; Jin, ZC; Chen, JJ; Ge, NJ; Ding, WB; Li, WH; Huang, JH; Mu, W; Gu, SZ; Li, JP; Zhao, H; Wen, SW; Lei, YM; Song, YS; Yuan, CW; Wang, WD; Huang, M; Zhao, W; Wu, JB; Wang, S; Zhu, X; Han, JJ; Ren, WX; Lu, ZM; Xing, WG; Fan, Y; Lin, HL; Zhang, ZS; Xu, GH; Hu, WH; Tu, Q; Su, HY; Zheng, CS; Chen, Y; Zhao, XY; Fang, ZT; Wang, Q; Zhao, JW; Xu, AB; Xu, J; Wu, QH; Niu, HZ; Wang, J; Dai, F; Feng, DP; Li, QD; Shi, RS; Li, JR; Yang, G; Shi, HB; Ji, JS; Liu, YE; Cai, Z; Yang, P; Zhao, Y; Zhu, XL; Lu, LG; Teng, GJ

Teng, GJ (通讯作者),Southeast Univ, Zhongda Hosp, Ctr Intervent Radiol & Vasc Surg, Med Sch,Dept Radiol, Nanjing 210009, Peoples R China.;Zhu, XL (通讯作者),Soochow Univ, Dept Intervent Radiol, Affiliated Hosp 1, Suzhou 215006, Peoples R China.;Lu, LG (通讯作者),Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai Intervent Med Ctr,Zhuhai Precis Med Ctr, Zhuhai 519000, Peoples R China.

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023; 8 (1):